General Information

General Information

DRAVP ID DRAVPe01541

Peptide Name GI-20X17

Sequence GIKEXKRIVQRIKDFLRNLV

Sequence Length 20

UniProt ID No entry found

Source Synthetic construct(derived from human cathelicidin LL-37)

Activity Information

Target Organism HIV

Assay

Activity

[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>40.6 μM).(EC50:50% effective concentration for inhibition of virus replication)

Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity

[Ref.18591279]CEM-SS cells:TC50=7.3 μM.(TC50:the concentration that reduced cell viability by 50%)

Binding Target Not found

Mechanism No machanism information found in the reference(s) presented in this entry

Structure Information

PDB ID None

Predicted Structure Download No predicted structure available

Linear/Cyclic Linear

N-terminal Modification Free

C-terminal Modification Free

Other Modification The 'X' at position 5 is phenylglycine

Stereochemistry L

Physicochemical Information

Formula C105H183N33O25

Absent amino acids ACHMPSTWY

Common amino acids IKR

Mass 2437.16

Pl 11

Basic residues 6

Acidic residues 2

Hydrophobic residues 8

Net charge 4

Boman Index -5252

Hydrophobicity -36.5

Aliphatic Index 126.5

Half Life

Mammalian:30 hour
Yeast:>20 hour
E.coli:>10 hour

Extinction Coefficient cystines 0

Absorbance 280nm 0

Polar residues 2

Literature Information

Literature 1

Title Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.

Pubmed ID 18591279

Reference Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.

Author Wang G, Watson KM, Buckheit RW Jr.

DOI 10.1128/AAC.00452-08